Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Viral video shows medical officer demanding Rs 500 from student in exchange for medical certificate, probe ordered

Rs 1 Lakh Bribe Deal Settled at Rs 30,000: Drug Inspector Nabbed by ACB

Farhat Nasim17 May 2025 8:38 PM IST

Charkhi Dadri: In a major crackdown on corruption, the Anti-Corruption Bureau (ACB) arrested a drug inspector and his broker for allegedly accepting a...

Lindane to Stay in Market for Lice, Scabies Treatment, Says DTAB

Farhat Nasim17 May 2025 8:37 PM IST

New Delhi: Refusing to impose a complete ban, the Drugs Technical Advisory Board (DTAB) has recommended the continued marketing of Lindane, a topical...

Mankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom Tablets

Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORA

Farhat Nasim16 May 2025 5:47 PM IST

New Delhi: The Delhi High Court has set aside the registration of the trademark "FLORASIS" filed by Zhejiang Yige Enterprise Management Group Co....

DTAB Agrees to Prohibit 16 FDCs Identified as Irrational

Farhat Nasim15 May 2025 9:02 PM IST

Delhi: In a major move to strengthen drug safety and rational prescribing practices, the Drugs Technical Advisory Board (DTAB) has recommended a ban...

DCGI Told to Act Against Unapproved Antibiotic FDCs

Farhat Nasim14 May 2025 7:48 PM IST

New Delhi: The Drugs Technical Advisory Board (DTAB), India's apex drug advisory body, has taken a firm stance on curbing the irrational use of...

Bombay HC Quashes 3% Reservation in Goa Medical Colleges for Children of Govt or Private Sector Employees

Bombay HC Notice to CDSCO on Denial of Phase I Trial for Indigenous Cancer Drug

Farhat Nasim12 May 2025 6:07 PM IST

Mumbai: The Bombay High Court has issued a notice to the Central Drugs Standard Control Organisation (CDSCO) and the Union government following a...

Doctors asked to only prescribe medicines available in hospital pharmacy

No Medicine Shortage: AIOCD Appeals to Chemists to Stay Alert and Serve as 'Jan Swasthya Rakshak'

Farhat Nasim10 May 2025 6:07 PM IST

New Delhi: In light of the escalating situation in India's sensitive border areas, the All India Organisation of Chemists and Druggists (AIOCD) has...

Delhi HC Clears Mankind Prime Labs' CROSSRELIEF Trademark for Registration

Farhat Nasim10 May 2025 6:05 PM IST

New Delhi: In a major relief to Mankind Prime Labs Pvt. Ltd., a subsidiary of Mankind Pharma Ltd., the Delhi High Court has set aside the Trade Marks...

Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac

Farhat Nasim9 May 2025 7:51 PM IST

Empagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.

CDSCO Committee Recommends SpinoS to Conduct BE Study with Vitamin D Screening Conditions

NPPA Slashes Retail Price of Vitamin D3 Oral Solutions Marketed by Aristo, Macleods

Farhat Nasim8 May 2025 8:25 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has corrected and reduced the retail prices of Cholecalciferol (Vitamin D3) oral...

UCPMP 2024: Govt Details Stricter Rules to Curb Gifts, Incentives from Pharma to Doctors

NMC Yet To Take Action Against 30 Doctors Named in Rs 1.91 Cr Freebie Case- RTI Response

Farhat Nasim8 May 2025 9:30 AM IST

New Delhi: Months after the Apex Committee for Pharma Marketing Practices (ACPMP) under the Department of Pharmaceuticals (DoP) reprimanded AbbVie...

Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist

Farhat Nasim7 May 2025 7:41 PM IST

New Delhi: Reckitt Benckiser, the company behind Dettol, has informed the Delhi High Court that it has reached a settlement with popular social media...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok